Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

TIROSINT Drug Profile

« Back to Dashboard
Tirosint is a drug marketed by Inst Biochimique, Institut Biochimique, and Ibsa Inst Bio. and is included in three NDAs. It is available from one supplier. There are two patents protecting this drug.

This drug has sixteen patent family members in nine countries.

The generic ingredient in TIROSINT is levothyroxine sodium. There are nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for Tradename: TIROSINT

Suppliers / Packagers: see list1
Bulk Api Vendors: see list37
Clinical Trials: see list3
Patent Applications: see list1,326
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIROSINT at DailyMed

Pharmacology for Tradename: TIROSINT

Drug Classl-Thyroxine
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ibsa Inst Bio
levothyroxine sodium
SOLUTION;ORAL206977-009Dec 15, 2016RXYesNo► subscribe► subscribe
Ibsa Inst Bio
levothyroxine sodium
SOLUTION;ORAL206977-010Dec 15, 2016RXYesNo► subscribe► subscribe
Inst Biochimique
levothyroxine sodium
CAPSULE;ORAL022121-001Aug 1, 2007RXNoNo7,723,390► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TIROSINT

Country Document Number Estimated Expiration
Denmark1433478► subscribe
Germany60207951► subscribe
European Patent Office1291021► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.